Parexel International Collaborates With Osaka International Cancer Institute

Parexel International said Monday that it is collaborating with Osaka International Cancer Institute to advance clinical development in Japan.

The company said the partnership will aim to drive greater efficiencies in support of patient recruitment for clinical trials in oncology and hematology, accelerating the development of innovative and effective new cancer treatments for patients.

Add Comment